Citadel Advisors’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,410
Closed -$7.28K 12721
2025
Q2
$7.28K Buy
2,410
+980
+69% +$2.77K ﹤0.01% 12214
2025
Q1
$4.07K Sell
1,430
-290
-17% -$1.28K ﹤0.01% 13919
2024
Q4
$10.1K Sell
1,720
-640
-27% -$3.61K ﹤0.01% 13616
2024
Q3
$10.5K Buy
2,360
+200
+9% +$4.69K ﹤0.01% 13200
2024
Q2
$57.2K Buy
2,160
+1,280
+145% +$30.2K ﹤0.01% 11608
2024
Q1
$24.1K Sell
880
-24,230
-96% -$769K ﹤0.01% 12875
2023
Q4
$610K Sell
25,110
-330
-1% -$5.85K ﹤0.01% 7668
2023
Q3
$514K Sell
25,440
-520
-2% -$13.3K ﹤0.01% 8014
2023
Q2
$766K Buy
25,960
+730
+3% +$20.8K ﹤0.01% 7020
2023
Q1
$631K Sell
25,230
-15,720
-38% -$506K ﹤0.01% 7823
2022
Q4
$1.3M Sell
40,950
-940
-2% -$29.6K ﹤0.01% 6315
2022
Q3
$1.24M Sell
41,890
-31,340
-43% -$1.08M ﹤0.01% 6520
2022
Q2
$2.23M Buy
73,230
+27,180
+59% +$2.49M ﹤0.01% 5321
2022
Q1
$6.22M Buy
46,050
+38,070
+477% +$4.01M ﹤0.01% 3757
2021
Q4
$1.04M Buy
7,980
+5,290
+197% +$669K ﹤0.01% 7851
2021
Q3
$252K Sell
2,690
-3,310
-55% -$337K ﹤0.01% 11460
2021
Q2
$614K Buy
+6,000
New +$1.05M ﹤0.01% 9561

Other funds holding LONA

Citadel Advisors's LONA Position: Q4 2025 in Review

Citadel Advisors sold out of LeonaBio Inc (LONA) in Q4 2025, closing a stake of 33,987 shares — an estimated $141K sold.

Citadel Advisors first reported a position in LONA in Q3 2020 and held it in 19 quarters. The position peaked at $39.8M in Q4 2020. 42 funds tracked by Wall St. Rank hold LONA as of Q4 2025.

  • Citadel Advisors reported no remaining LeonaBio Inc position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 33,987 LeonaBio Inc shares in Q4 2025, an estimated $141K.
  • Citadel Advisors first reported a position in LeonaBio Inc in Q3 2020 and held it in 19 quarters.
  • Citadel Advisors's LeonaBio Inc position peaked at $39.8M in Q4 2020.
  • 42 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.